Sökning: "multiple sclerosis viral"
Visar resultat 1 - 5 av 16 avhandlingar innehållade orden multiple sclerosis viral.
1. Viral proteins as serological antigens - Development and clinical applications
Sammanfattning : Serological methods are based on the detection of antibodies and antigens in mainly serum but also in other body fluids such as cerebrospinal fluid (CSF). Conventional whole virus antigens are widely used in viral serological assays. LÄS MER
2. Biomarkers and viral risk factors in multiple sclerosis
Sammanfattning : Multiple sclerosis (MS) is a chronic inflammatory disease resulting in axonal injury and demyelination of nerve fibers in the central nervous system. The causal factor and pathological mechanisms governing disease progression have remained elusive, limiting the available clinical tools for MS diagnosis and treatment monitoring, particularly in the periphery. LÄS MER
3. Epidemiological analysis of viral infections as risk factors for multiple sclerosis
Sammanfattning : Viral childhood diseases have been implicated in the pathogenesis of multiple sclerosis (MS). Swedish mass vaccination programmes resulted in radical changes in the panorama of the targeted infections. Vaccines against measles, mumps and rubella were implemented in the early 1970s. LÄS MER
4. Human herpesvirus-6 in multiple sclerosis : assay development, immune responses and host genetics
Sammanfattning : MS is a chronic inflammatory demyelinating disease of the CNS that implies impaired motor- and cognitive functions. Life expectancy is not severely affected but the disease has substantial negative effects on the quality of life of patients and their relatives. LÄS MER
5. Establishment and applications of a multiple sclerosis biobank : analysis of biomarkers and therapeutic complications in MS
Sammanfattning : Biomarkers for disease activity and prognosis in multiple sclerosis (MS) are lacking. We established a MS biobank consisting of paired cerebrospinal fluid samples (CSF) and peripheral blood samples from MS patients and controls. LÄS MER